Xennials Therapeutics
  • Home
  • About Xennials
  • Technology & Pipeline
  • Clinical Trials
  • News
  • Contact Us
Select Page

Nanotechnology in Cancer Research

by Lynn Bell | May 31, 2018 | Latest News

Nanotechnology is the application of materials, functionalized structures, devices, or systems at the atomic, molecular, or macromolecular scales. At these length scales, approximately the 1-100 nanometer range as defined by the U.S. National Nanotechnology Initiative...

Categories

  • Latest News

Recent Posts

  • XNTR-20-02 Study Update
  • Xennials Therapeutics Australia Pty Ltd, in collaboration with PinotBio Inc., announces the enrollment of First patient in to the Phase 1/2 study of NTX-301 as a single agent and in combination with Standard of Care in selected solid tumors
  • Xennials Therapeutics Australia Pty Ltd, in collaboration with PinotBio Inc., announces the start of a new Phase 1/2 study of NTX-301 as a single agent and in combination with Standard of Care in selected solid tumors
  • Nanotechnology in Cancer Research

Archives

  • June 2022
  • September 2021
  • May 2021
  • May 2018

BROWSE

Home
About Xennials
Meet the Team
Board of Directors
Technology & Pipeline

 

 

CONTACT

  • UNITED STATES
    Xennials Therapeutics Inc.
    John Hancock Tower
    875 N. Michigan Ave.
    Suite 3100
    Chicago, IL 60611
    Office: +1 (312) 344-3715
  • SYDNEY, AUSTRALIA
    Xennials Therapeutics Australia Pty Ltd, Level 14, 60 Margaret Street, Sydney NSW 2000, Australia
    Tel: +61 (499) 929-480

 

© 2019 Xennials Therapeutics Inc. All Rights Reserved.